Pharmachem Innovations
Pharmachem Innovations is a B2B nutraceutical ingredients company that develops proprietary branded ingredients, delivery systems, and contract manufacturing services for nutritional product companies, CMOs, and DTC supplement brands in 70+ countries.
- Company typePrivate
- Founded1972
- HeadquartersKearny, United States
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
What Pharmachem Innovations does
Pharmachem Innovations is a B2B nutraceutical ingredients company that develops, manufactures, and supplies proprietary branded specialty ingredients, delivery systems, and custom formulation services to nutritional product companies, contract manufacturing organizations (CMOs), and MLM/fulfillment/direct-to-consumer supplement brands. Its core product portfolio is anchored by clinically supported branded ingredients—Phase 2™ Carb Controller (white kidney bean extract, 14+ human studies), GPM™ Fermented Nutrients (glycoprotein-matrix fermented vitamins and minerals), Prenulin™ Blend (blood sugar management), Perluxan™ (hops extract for joint health), and Cran-Max™ (whole-fruit cranberry concentrate with FDA-qualified health claims). These branded ingredients sit on top of proprietary delivery and processing platforms including Acti-Solve™ particle engineering, Bio-Shield™ encapsulation, Nutrapress™ BND and CHW organic tablet binders, and StableFizz™ effervescent granulation, with distribution partnerships extending the catalog into Probiotical® probiotics (Italy) and Waitaki Biosciences® ingredients (New Zealand).
The business operates three revenue streams: (1) proprietary branded ingredient sales (licensing/royalty-like economics on ingredients sold to brands), (2) custom formulation and contract/toll manufacturing services, and (3) private label and market-ready pre-blended products. Pricing is quote-based B2B and not publicly disclosed. The company is headquartered in Kearny, New Jersey, with manufacturing facilities in New Jersey, Utah, and Tamaulipas, Mexico, and reaches customers in 70+ countries. Following its August 2024 acquisition from Ashland Inc. by Turnspire Capital Partners, Pharmachem launched as an independent company on September 3, 2024, with Árpád Széchényi joining as President and CEO in May 2025.
Pharmachem Innovations firmographics
Firmographics- Name
- Pharmachem Innovations
- Legal name
- Pharmachem Laboratories, LLC
- Website
- https://pharmachem.com
- Company type
- Private
- Founded year
- 1972
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Pharmachem Innovations is a B2B nutraceutical ingredients company that develops proprietary branded ingredients, delivery systems, and contract manufacturing services for nutritional product companies, CMOs, and DTC supplement brands in 70+ countries.
- Ownership category
- akta.pro rank
Pharmachem Innovations industry classification
Industry- Product category
- Nutraceutical Ingredients
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411), Drugs and Druggists' Sundries Merchant Wholesalers (4242)
- SIC
- Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives (EUAAAIAK)
Keywords
Where Pharmachem Innovations is headquartered
LocationHeadquarters
- HQ city
- Kearny
- HQ country
- United States
- HQ region
- North America
Offices4 records
Markets served
Pharmachem Innovations business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Proprietary Branded Ingredients: Revenue from proprietary branded ingredients including Phase 2™ Carb Controller, GPM™ fermented nutrients, and other specialty ingredients sold to nutritional product companies
- Custom Formulation and Manufacturing Services: Contract manufacturing and custom formulation services for brands and CMOs
- Private Label Products: Private label manufacturing of nutritional supplements and ingredients
Go-to-market motion1 record
Distribution channels2 records
Marketing channels5 records
Pharmachem Innovations product offering
Product offeringCore offering
Pharmachem Innovations develops and manufactures proprietary branded nutraceutical ingredients (such as Phase 2 Carb Controller, GPM Fermented Nutrients, and Cran-Max) and provides custom formulation and contract/toll manufacturing services to nutritional product companies, CMOs, and MLM/DTC brands. The company operates manufacturing facilities in New Jersey, Utah, and Tamaulipas, Mexico, and distributes its ingredient portfolio to customers in more than 70 countries.
Product overview
Pharmachem Innovations is a B2B nutraceuticals ingredients company offering a portfolio of branded specialty ingredients, proprietary delivery systems, and custom manufacturing services. The core branded ingredient portfolio includes five flagship products: Phase 2™ Carb Controller (white kidney bean extract for weight management), GPM™ Fermented Nutrients (fermented vitamins/minerals platform with improved bioavailability), Prenulin™ Blend (blood sugar management), Perluxan™ Hops Extract (joint health), and Cran-Max™ Cranberry Concentrate (urinary tract health). Supporting these are proprietary delivery systems including Nutrapress™ BND (organic tablet binder), Nutrapress™ CHW (organic chewable base), and StableFizz™ effervescent granulation, plus the Acti-Solve™ particle engineering platform for ingredient optimization. The company also distributes performance ingredients including Probiotical® probiotics from Italy, Waitaki Biosciences® ingredients from New Zealand, and NordicCherry® tart cherry extract. Services include custom formulation, contract/toll manufacturing, and market-ready pre-blended solutions for faster commercialization.
Differentiator
Problem solved
Functional benefit
Brands
- Phase 2™ Carb Controller: Proprietary white kidney bean extract for weight management, clinically studied to reduce starch absorption by up to 66%.
- GPM™ Fermented Nutrients
- Prenulin™ Blend
- Perluxan™ Hops Extract
- Cran-Max™ Cranberry Concentrate
- Nutrapress™ BND
- Nutrapress™ CHW
- Probiotical® Probiotics
- Waitaki® Biosciences
- Acti-Solve™
- StableFizz™
Products and services
- Phase 2 Carb Controller
Companies that use Pharmachem Innovations
Customer profileSegments3 records
Ideal customer profiles3 records
Pharmachem Innovations technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Pharmachem Innovations partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- Probiotical S.p.A.coreItalian manufacturer of probiotics that Pharmachem distributes in North America. This strategic partnership extends Pharmachem's portfolio into the probiotics category, leveraging their distribution network and customer relationships.
- Waitaki BiosciencescoreNew Zealand company whose ingredients Pharmachem distributes, expanding their geographic reach and ingredient portfolio with New Zealand-sourced specialty ingredients.
- Ashland Inc. (NYSE: ASH)minorPrevious owner of the Pharmachem business prior to acquisition by Turnspire Capital Partners in August 2024. Ashland sold the business as part of their portfolio optimization strategy.
Scale indicators3 records
Recent moves7 records
Expansion highlights6 records
Pharmachem Innovations competitors and assessment
Company assessmentBroad incumbents
- DSM-Firmenich: Global ingredients giant with a deep health, nutrition and care portfolio (vitamins, premixes, HMOs, omega-3) — competes with Pharmachem across multiple categories and has the scale and R&D budget to outpace smaller specialty players.
- Cargill Health & Nutrition: Cargill's health ingredients and contract manufacturing arm (including the former Provimi and Diamond V premix businesses) supplies nutritional brands globally — a broad incumbent with overlapping CDMO and specialty ingredient capabilities.
- ADM Health & Wellness: Archer Daniels Midland's Health & Wellness segment offers flavors, colors, and functional ingredients for supplements and functional foods — broad portfolio competitor with global reach that overlaps with Pharmachem's custom formulation and branded ingredient lines.
- Lonza Capsules & Health Ingredients: Division of Lonza Group supplying capsules, particle engineering, and specialty health ingredients globally — adjacent technology overlap (notably particle engineering, similar to Acti-Solve) and a direct competitor for CDMO and specialty ingredient contracts.
Direct peers
- Glanbia Nutritionals: Global B2B supplier of premix solutions, specialty proteins, and ingredient systems for the nutrition and supplement industry, combining proprietary ingredients with custom formulation/contract manufacturing — overlapping with Pharmachem's three-pillar model.
- Sabinsa Corporation: Privately held US-headquartered manufacturer of patented, clinically validated branded nutraceutical ingredients (Curcumin C3 Complex, BioPerine, etc.) sold to global supplement brands — a near-direct analog to Pharmachem's Phase 2/GPM/Perluxan model.
- Indena SpA: Italian manufacturer of high-purity botanical extracts and active pharmaceutical ingredients with a branded portfolio (e.g., Meriva, Quercefit) sold globally to nutraceutical and pharma customers — directly comparable botanical ingredient business.
- Gnosis by Lesaffre: Business unit of Lesaffre focused on human nutrition ingredients including probiotics, yeasts, and vitamins, with proprietary branded technologies (e.g., Lynside, LifeinU) — overlapping directly with Pharmachem's GPM and Probiotical franchises.
- PLT Health Solutions: US-based B2B ingredient platform offering a portfolio of proprietary branded nutraceutical ingredients backed by clinical research, distributed globally to supplement and functional food brands — closely comparable branded ingredients business model.
- Kemin Industries: Privately held global ingredient manufacturer with proprietary, science-backed branded ingredients in human nutrition (and animal nutrition), serving similar B2B brand customers and contract manufacturing partners.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Pharmachem Innovations social profiles
Digital presencePharmachem Innovations compliance and trust
Trust signalCompliance7 records
Pharmachem Innovations financial estimates
Financial estimateRevenue estimate
Valuation estimate
Pharmachem Innovations leadership team
Management profileNumber of profiles
Profiles2 records
Pharmachem Innovations funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Pharmachem Innovations M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Pharmachem Innovations
What does Pharmachem Innovations do?
Pharmachem Innovations develops and manufactures proprietary branded nutraceutical ingredients (such as Phase 2 Carb Controller, GPM Fermented Nutrients, and Cran-Max) and provides custom formulation and contract/toll manufacturing services to nutritional product companies, CMOs, and MLM/DTC brands. The company operates manufacturing facilities in New Jersey, Utah, and Tamaulipas, Mexico, and distributes its ingredient portfolio to customers in more than 70 countries.
Is Pharmachem Innovations a public or private company?
Pharmachem Innovations is a private company. It is classified as private equity controlled and is currently operating.
When was Pharmachem Innovations founded?
Pharmachem Innovations was founded in 1972. It employs 251 to 500 people.
Where is Pharmachem Innovations based?
Pharmachem Innovations is headquartered in Kearny, United States, in the North America region.
How does Pharmachem Innovations make money?
Three revenue lines are on record. Proprietary Branded Ingredients are the primary driver. The others are custom Formulation and Manufacturing Services and private Label Products.
Who are Pharmachem Innovations's main competitors?
Broad incumbents on record are DSM-Firmenich, Cargill Health & Nutrition, ADM Health & Wellness and Lonza Capsules & Health Ingredients. Direct peers are Glanbia Nutritionals, Sabinsa Corporation, Indena SpA, Gnosis by Lesaffre, PLT Health Solutions and Kemin Industries.
Does Pharmachem Innovations have an API?
No public API is recorded for Pharmachem Innovations.
What industry is Pharmachem Innovations in?
Pharmachem Innovations's product category is Nutraceutical Ingredients. Its primary akta.pro industry code is EUAAAIAK, Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives. Its NAICS code is 325412 and its SIC code is 2834.